EDGEMOND JAMES sold UTHR
June 22, 2026 · Form 4 insider transaction
EDGEMOND JAMES sold 1,250 shares of United Therapeutics Corporation at $541.25 per share, a transaction worth $676.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,250
Price
$541.25
Total value
$676.6K
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 22, 2026
Filing dateJune 23, 2026
Shares owned after18,876
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.